(NU/1887) Gene Editing iPSC for Haematopoietic Disease Modelling
What the buyer wrote
The project concerns work described in a Wellcome Trust Investigator Award which requires the differentiation and functional assessment of macrophages from iPSC carrying mutations of clonal haematopoiesis including TET2 frameshift, DNMT3A R882 and BRAF V600E. Funding in the application is available for a research partner to supply these reagents.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Supplier not named
Details
- What the buyer calls it
- (NU/1887) Gene Editing iPSC for Haematopoietic Disease Modelling
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
- Where
- in the North East
- Kind of work
- Research, evaluation and insight
Who the buyer named
Dave Anderson was the named contact on this notice.